The leading network of specialized online medical communities

Citeline’s Skipta is the leading network of specialized online medical communities for over 800,000 verified healthcare professionals. Providing the perfect opportunity for pharma marketers, Skipta brings together 25 communities, segmented by specialty and disease area, on a private and secure platform where members access news, clinical data and more. 

Pharmaceutical marketer accessing Skipta's network of healthcare professionals.

Skipta allows pharmaceutical marketers to target the right physicians in a highly valued, information-rich, and trusted setting. It provides multiple routes to engage and educate healthcare providers, helping establish trust and build connections that traditional marketing often cannot. 

How Skipta helps 

Skipta’s network is made up of verified HCP members seek clinically relevant information in communities segmented by specialty and disease area. With Skipta, you can:

  • reach a social network of 800,000+ verified healthcare professionals
  • target HCPs relevant to your brand
  • get your brand noticed by HCPs who are ready to engage

How is Skipta different? 

Skipta does much more than provide a digital marketing platform. It enables engagement and relationship-building. 

What's included
Peer-to-peer collaboration

Skipta is comprised of many tools that allow registered medical professionals to consult, communicate and exchange information in a private, secure platform.

Speciality focused clinical updates

Stay up to date with relevant journal articles and topline summaries. Our medical staff scans hundreds of journal articles and curates the most relevant along with summaries of key clinical findings.

Real-time patient cases 

Consult with colleagues in real time on challenging patient cases - crowdsource diagnoses, gain input on potential treatment options and next steps. Commenters are often randomly selected to earn honoraria for sharing their insights!

Understand more about how our solutions can help you gain a competitive advantage
Our experts
With more than 400 subject-matter experts in key global markets, Citeline is poised to help life science organizations make informed business decisions. Our expertise runs the full gamut of the drug development life cycle, from clinical planning to regulatory and patient engagement and recruitment.

As a full-service partner, we can add value where it’s needed - at any point in the marketing and sales funnel . We support your in-house marketing teams where they need it most, leaving them to focus on other priorities and to accelerate your marketing capabilities.
Two people sitting and talking together.
Person sitting at a desk working. Two people looking at a file together.

Related resources

a woman sitting at a table talking to a doctor
JUN 14, 2023

Patient Voice to Data: How Novartis Is Listening Up, Harnessing RWE in APMA

Novartis APAC President Iris Zemzoum says Novartis is empowering patients and also partnering across the diverse region to leverage real-world evidence.

EMIS logo
NOV 09, 2022
Press Release

Citeline and EMIS Partner to Expand Clinical Trial Access in the UK

Citeline’s new Sitetrove Diversity Module marries robust site and investigator intelligence with patient age, race and gender data, enabling data-driven decision making to support the diversification of clinical trials.

Several hands, adorned with gloves, united to form a heart.
OCT 18, 2023
Patient Engagement & Recruitment

Patients Front and Center: Involving the Patient in Clinical Trial Design

The pharma industry continues to look for ways to boost patient recruitment. See patient, caregiver, and benefits provider perspectives on this issue.

Speak to a Specialist
A specialist is ready to help find the solutions that are right for you.
Professionals submitting a form to find out more about Citeline.

Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.